• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management

Interview Intersection: Expert Interviews From June 2024


Dermatology Times is recapping our top expert interviews from the month of June.

Interview Intersection logo

Exploring Oral Options for Psoriasis Therapies

Ben Lockshin, MD, FAAD, delves into the new generation of oral psoriasis therapies to enhance patient quality of life.

Navigating the Alopecia Areata Treatment Landscape

James Song, MD, discusses the current treatment landscape, genetic and immunological influences, and the role of oral minoxidil in alopecia areata.

Unraveling the Advancements in Seborrheic Dermatitis Treatment

Raj Chovatiya, MD, PhD, takes a deep dive in the challenges, solutions, and further research needed to treat seborrheic dermatitis.

Talking About JAKs: Best Practices for Effective Patient Communication

Raj Chovatiya, MD, PhD, focused on understanding JAK inhibitors, discussing their clinical use and safety profiles for effective patient communication.

Generalized Pustular Psoriasis: Recent Advancements, Resources, and Cytokine Considerations

Jason Hawkes, MD, MS, gives an overview of what clinicians need to know today about this rare condition.

Deciphering Atopic Dermatitis Therapy Options

James Song, MD, addressed current challenges in the AD treatment landscape and compared biologics.

2024 Pediatric Pearls With Karan Lal, DO

The country's only double-board certified pediatric and cosmetic dermatologist shared what he learned from 5 unique patient cases this year.

Boxed Warnings: What Should Dermatology Clinicians Know?

Jason Hawkes, MD, MS, breaks down boxed warning pros and cons and research addressing several boxed warnings.

Biologics and Pregnancy: A Q&A With Ben Lockshin, MD

Lockshin shared his approach to continuing biologic therapies into pregnancy with informed timing adjustments.

Topics and Pearls

  • Disease states such as PsO, PsA, GPP, HS, seborrheic dermatitis, alopecia areata, atopic dermatitis, skin cancer, and vitiligo
  • Insights into risks associated with JAKs, biologics, and systemics
  • Pediatric dermatology pearls
  • Innovation and advancements in artificial intelligence, pathogenesis, and pathways
  • Spotlighting advanced practice providers and APP organizations

Combining Systemic Therapies in Psoriasis and Atopic Dermatitis

James Song, MD, explains combination treatment efficacy, addresses comorbidities, and provides pearls to improve patient safety.

Understanding the Mechanism of Action in JAK Inhibitors

Jason Hawkes, MD, MS, detailed each of the kinases' association with different cytokine receptors and biological functions.

Joseph Zabinski, PhD, MEM: Navigating the Future of AI in Skin Cancer Detection

Zabinski, vice president and head of commercial strategy and AI at OM1, discusses the evolving role of AI in dermatology, focusing on its potential and challenges in skin cancer detection.

Global Hidradenitis Suppurativa Atlas Produces Report Aimed at Advancing Knowledge and Awareness of HS

Henry Lim, MD, discusses key findings and areas of improvement identified by the report, as well as his hopes for HS treatment moving forward.

Introducing Karan Lal, DO, MS, FAAD: Dermatology Times' Newest Editorial Advisory Board Member

Karan Lal, DO, MS, FAAD, is a double-board certified pediatric and cosmetic dermatologist at Affiliated Dermatology in Scottsdale, Arizona.

Spotlighting Vitiligo: New Innovations to be Presented at RAVE 2024

Nanette Silverberg, MD, shares her excitement about the inclusion of vitiligo at this year’s RAVE meeting.

A RAVE Upgrade: Previewing Revolutionizing Alopecia Areata, Vitiligo, and Eczema

Jonathan Silverberg, MD, PhD, MPH, shares insights into the change of this year’s meeting and the benefit of additional disease states.

Considerations for Topical Therapeutics and Clinical Excellence in Vitiligo

Nanette Silverberg, MD, shares data on the efficacy of on- and off-label therapeutics for vitiligo, as well as the importance of communication with patients to promote clinical excellence.

Don’t Forget to Address Autoimmune Comorbidities of Atopic Dermatitis

Jonathan Silverberg, MD, PhD, MPH, presented his tips for effectively treating atopic dermatitis without worsening autoimmune comorbidities.

What’s New in Devices for Vitiligo?

Karan Lal, DO, dives into the benefits of combination therapy for vitiligo with topicals and devices.

Safety vs Efficacy: What AD Treatments Can Be Used in Pediatric Patients?

Amy Paller, MD, reviews the various types of therapeutics available and coming soon for pediatric atopic dermatitis and how she decides what treatment approach is best for each patient.

Comparing AD Guidelines From Around the World

Robert Sidbury, MD, MPH, addresses the similarities and differences between the AAD’s recent atopic dermatitis guidelines and other guidelines from various groups and countries.

Exploring New Pathways in Atopic Dermatitis

Melinda Gooderham, MSc, MD, FRCPC, discusses potential new biologics for atopic dermatitis that target IL-22, IL-33, OX40, and more.

Looking Ahead to Advancements in Vitiligo and Atopic Dermatitis

David Rosmarin, MD, shares key points from phase 3 data of ruxolitinib for vitiligo, as well as highlights the potential for targeting the STAT pathway in upcoming atopic dermatitis therapeutics.

Addressing Itch and Remission in Atopic Dermatitis

Raj Chovatiya, MD, PhD, discusses how approved AD therapeutics currently address itch and whether any therapeutics will eventually have a remittive effect.

Prioritizing Itch and Sleep Improvement in Atopic Dermatitis

Gil Yosipovitch, MD, addresses the severity of chronic itch and sleep disturbances in patients with atopic dermatitis.

Alice Gottlieb, MD, PhD: Preventing Pain and Disability in Psoriatic Disease

Gottlieb reviews her lecture from the Society for Investigative Dermatology Annual Meeting.

Fostering Mentorship and Support in Early-Stage Physician Assistants

Aubrie Jones, PA-C, MMS, and Laura Bush, DMSc, PA-C, DFAAPA, discuss the role of the SDPA in supporting the growth and journeys of PAs at all stages.

Top 5 Strategies to Switch From Practice to Pharma

Terry Arnold, PA-C, shares a wide range of opportunities to take clinical experience to a different setting and tips to transition.

Addressing the Health Impacts of a Changing Climate

Ethan Sims, MD, spoke with Dermatology Times on having positive conversations, cutting down on waste, and how to get involved in change.

Patient and Expert Perspectives From the “I LUV YA for the Long Haul” Plaque Psoriasis Campaign

Omar Noor, MD, and a patient with psoriasis share their unique perspectives on moderate to severe plaque psoriasis treatment with tildrakizumab.

Modern Dermatology: Advanced Meds and Social Media Myths

Rob Casquejo, PA-C, spoke with Dermatology Times on new and upcoming medications, addressing unmet needs, and social media misinformation.

Alexandra Golant, MD: Insights from Olympic Athlete Suni Lee's Journey with Atopic Dermatitis

Eli Lilly recently hosted a panel discussion with Olympic athlete Suni Lee to discuss the importance of finding a dermatologist who understands the burden of AD.

The Role of Laser Treatments in Preventing Skin Cancer

Patricia Richey, MD, delves into efficacy of the 1927 and 1550 nanometer lasers to prevent skin cancers.

Laura Bush on Dermatology PA Advancements

Laura Bush reflects on her term as SDPA president, discussing achievements, challenges, and the future of dermatology PAs in health care.

Seth Matarasso, MD, Addresses Counterfeit Botox News and How to Move Forward

The recent news of counterfeit Botox resulted in patients with blurred vision, difficulty swallowing, shortness of breath, and additional symptoms.

Beyond Aesthetics: The Vital Role of Nails in Health

Martin Zaiac, MD, gave insight on potential risks associated with manipulation of nails, hygiene, and when it is necessary to see a specialist.

SFA-002 Shows Promise in Early Clinical Trial Psoriasis Cohorts

Stefan Weiss, MD, MBA, explains next steps for the oral treatment after the completion of phase 1b enrollment.

Antimicrobial Resistance: Challenges and Potential Solutions

Stephen Tyring, MD, PhD, MBA, covers the burden of antimicrobial resistance and the need for alternative treatments.

Amber Blair, PA-C, Shares Innovative Insights as SDPA President-Elect

Renata Block, MMS, PA-C, and Amber Blair, MMS, PA-C, discuss the gratification of helping patients and the excitement of being on the cutting edge of research.

Navigating Challenges and Advancements in Alopecia Areata Treatment

Maryanne Makredes Senna, MD, shares insights into the complexities of treating alopecia areata and guidance for clinicians.

Turn Therapeutics' Atopic Dermatitis Candidate Achieves 57% Reduction in Disease Severity in 7 Days

Bradley Burnam discusses results from an in-vivo model of atopic dermatitis.

Don’t miss a moment of Dermatology Times by signing up for our eNewsletters and subscribing to receive the free print issue and supplements each month.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.